Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Industry Fears 'Double Taxation' For Combo Products, Device Kits

This article was originally published in The Gray Sheet

Executive Summary

Internal Revenue Service guidance on the medical device tax should ensure that combination products and other items are not double-taxed, AdvaMed and other industry stakeholders say.

You may also be interested in...



Tax Time Cometh: IRS Issues Device Tax Proposed Rule

IRS issued the draft regulation in the lead up to the Jan. 1, 2013, launch date of the 2.3% federal excise tax on most U.S. device sales, enacted in 2010 under the Affordable Care Act. The agency is collecting comments on the proposal through May and will hold a public meeting May 16.

Debate Over Device Tax Guidance Divides Hospitals, MedTech Groups

Hospitals and group purchasers are pressing the Internal Revenue Service to develop regulations that would make it more difficult for medical technology firms to pass the costs of the upcoming device excise tax onto customers.

AdvaMed Seeks Broad Exemptions From Medical Device Excise Tax

The Internal Revenue Service should be flexible in deciding which medical devices will be exempt from a new excise tax, AdvaMed says.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT030347

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel